Ex-Merck insider trading prosecution

Matter type

White collar

Venue

Federal district court

Outcome

Insider trading charges — guilty plea negotiation

Why this matter was high-stakes

Merck analyst defendant
Federal insider trading
SEC/DOJ enforcement
Professional collateral consequences

The charges

The client, a former Merck analyst, faced federal insider trading charges arising from securities transactions tied to non-public pharmaceutical information. SEC and DOJ enforcement in this space carries substantial guidelines exposure and professional collateral consequences.

White-collar strategy

Insider trading cases turn on material non-public information, scienter, and the chain of communication from source to trade. The defense evaluated trial risk against sentencing exposure and collateral consequences for a professional whose career depended on the outcome.

Resolution

The matter resolved through negotiated disposition—reflecting the firm's approach of matching strategy to client goals, whether trial, plea, or sentencing advocacy.

Industry context

Pharmaceutical and securities enforcement actions require counsel who understand both the regulatory framework and the personal stakes for professionals whose licenses and careers hang in the balance.

Attorney advertising. Past results do not guarantee future outcomes.

← All representative matters · Request a review · Media archive

Press archive